iMunich is one of Europe’s leading biotech regions with more than 200 companies in the life science sector (biotech, pharma, CROs, suppliers, a.o.). The location benefits in particular from the close interaction between academic research and the biotech industry. Bavarian biotech is characterized by a strong focus on diagnostics and therapeutics, personalized medicine, immune oncology and digital medicine.
Join our presentation to learn more about why you should invest in Germany.
Session ID: 21918